PUMA BIOTECHNOLOGY, INC.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2017 | — | $-73.2M | $-72.9M |
| Jun 2017 | — | $-78.2M | $-77.8M |
| Sep 2017 | $6.1M | $-77.4M | $-77.2M |
| Dec 2017 | $21.6M | — | $-64.1M |
| Mar 2018 | $66.5M | $-23.4M | $-24.3M |
| Jun 2018 | $50.8M | $-41.4M | $-44.3M |
| Sep 2018 | $62.6M | $-11.3M | $-14.2M |
| Dec 2018 | $71.1M | — | $-30.7M |
| Mar 2019 | $99.1M | $9.8M | $-10.1M |
| Jun 2019 | $53.9M | $-25.8M | $-37.4M |
| Sep 2019 | $56.4M | $-14.4M | $-16.9M |
| Dec 2019 | $62.9M | — | $-11.2M |
| Mar 2020 | $51.2M | $-14.3M | $-16.9M |
| Jun 2020 | $70.6M | $7.1M | $3.4M |
| Sep 2020 | $50.8M | $-12.1M | $-31.5M |
| Dec 2020 | $52.6M | — | $-15.0M |
| Mar 2021 | $98.2M | $20.1M | $16.5M |
| Jun 2021 | $53.4M | $-16.6M | $-5.1M |
| Sep 2021 | $46.2M | $-9.0M | $-44.7M |
| Mar 2022 | $45.7M | $-747.0K | $-3.4M |
| Jun 2022 | $59.5M | $12.1M | $9.4M |
| Sep 2022 | $57.1M | $2.4M | $-360.0K |
| Mar 2023 | $52.8M | $4.4M | $1.4M |
| Jun 2023 | $54.6M | $4.9M | $2.1M |
| Sep 2023 | $56.1M | $8.6M | $5.8M |
| Mar 2024 | $43.8M | $-2.3M | $-4.8M |
| Jun 2024 | $47.1M | $-2.2M | $-4.5M |
| Sep 2024 | $80.5M | $22.1M | $20.3M |
| Mar 2025 | $46.0M | $4.0M | $3.0M |
| Jun 2025 | $52.4M | $6.6M | $5.9M |
| Sep 2025 | $54.5M | $9.6M | $8.8M |
| Mar 2026 | $44.8M | $-3.8M | $-3.8M |
| Jun 2026 | $56.5M | $7.6M | $8.2M |